Isabl

Active

Cancer tests based on whole genome and transcriptome data.

Winter 2020Founded 20205 peopleNew York, NY, USA; Remote

↻ Pivot / rename signal

This company has previously operated under “Isabl Technologies”. A rename frequently marks a pivot in positioning or product — useful raw material for variant ideas.

About

Isabl has developed software that can analyze the entire genome of cancer patients. Today, when people get cancer, they get a genetic test of their tumor that analyzes only a few possible mutations. With Isabl, you run the tumor through an Illumina sequencer and get the whole genome, then our software is able to analyze all the mutations. Our breakthrough technology provides unprecedented clarity into tumor biology to aid treatment planning. This opens up opportunities for precision diagnostics, disease surveillance and biomarker discovery.